Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (2342)	10/15/1997 4:25:00 PM
From: Steve Fancy	of 6136

Well, spoke to soon. The stock has been trading with a definite downside bias the last couple of days. It's moving with the market to some degree. Look's to me that it may continue to trend downward in the absence of good news and/or analysts reaffirming that the stock is a good buy at these levels. The stock has been slowly loosing ground on slowly rising volume...not good. Sounds like confidence is sinking and investors are bailing. Sadly, with good reason, in that I don't believe anyone has released a rebuttal (on the newswires) to the negative twists that were scrounged up at the ICAAC conference, let alone comment on the strong earnings and forward looking forcasts. Unfortunately the comment of "letting our earnings speak for themselves" by an Agouron spokesperson, appears to have not been strong enough to offset future concerns raised recently. The Sunday New York Times didn't help either with suggestions that the stock was a good buy under 50. After all the hype, a real disappointment to date. sf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next